VeriMom¿Es human cord blood progenitor cell exosomes seguro durante el embarazo?
No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
Related ingredients
Frequently asked questions
- ¿Es human cord blood progenitor cell exosomes seguro durante el embarazo?
- No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
- ¿Es human cord blood progenitor cell exosomes seguro durante la lactancia?
- No specific regulatory or peer‑reviewed data showing harm via breastmilk or effects on lactation. Theoretical mechanism exists (bioactive cargo could in theory be transferred systemically and into milk), but there is no empirical evidence. Dermal exposure for lactating persons is expected to be low but measurable.
- ¿Es human cord blood progenitor cell exosomes seguro para la piel del bebé?
- No data demonstrating developmental/infant toxicity from topical use. Mechanistic theoretical concern persists (bioactivity of exosome cargo). Exposure score increased by +1 for infants because immature skin has higher permeability and higher surface‑area‑to‑weight; if adult exposure is low/measurable (1), infant exposure is judged as moderate (2). No infant‑specific absorption or toxicity studies were identified.
- ¿Cómo puntúa VeriMom a human cord blood progenitor cell exosomes?
- VeriMom puntúa human cord blood progenitor cell exosomes en 87/100 (riesgo bajo) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a human cord blood progenitor cell exosomes en el embarazo?
- Consulta nuestra lista de alternativas seguras a human cord blood progenitor cell exosomes según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.